Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

USA - NYSE:RBLX - US7710491033 - Common Stock

135.06 USD
+3.02 (+2.29%)
Last: 9/26/2025, 8:26:18 PM
135.08 USD
+0.02 (+0.01%)
After Hours: 9/26/2025, 8:26:18 PM
Fundamental Rating

4

Taking everything into account, RBLX scores 4 out of 10 in our fundamental rating. RBLX was compared to 80 industry peers in the Entertainment industry. While RBLX seems to be doing ok healthwise, there are quite some concerns on its profitability. RBLX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

RBLX had negative earnings in the past year.
In the past year RBLX had a positive cash flow from operations.
In the past 5 years RBLX always reported negative net income.
In the past 5 years RBLX always reported a positive cash flow from operatings.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of RBLX (-12.14%) is worse than 70.00% of its industry peers.
Looking at the Return On Equity, with a value of -269.61%, RBLX is doing worse than 78.75% of the companies in the same industry.
Industry RankSector Rank
ROA -12.14%
ROE -269.61%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 78.01%, RBLX belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Gross Margin of RBLX has remained more or less at the same level.
RBLX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBLX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RBLX has more shares outstanding
Compared to 1 year ago, RBLX has an improved debt to assets ratio.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 6.56 indicates that RBLX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.56, RBLX belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
The Debt to FCF ratio of RBLX is 1.07, which is an excellent value as it means it would take RBLX, only 1.07 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of RBLX (1.07) is better than 82.50% of its industry peers.
RBLX has a Debt/Equity ratio of 2.85. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.85, RBLX is not doing good in the industry: 76.25% of the companies in the same industry are doing better.
Although RBLX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 1.07
Altman-Z 6.56
ROIC/WACCN/A
WACC8.78%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.97 indicates that RBLX may have some problems paying its short term obligations.
The Current ratio of RBLX (0.97) is comparable to the rest of the industry.
RBLX has a Quick Ratio of 0.97. This is a bad value and indicates that RBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
RBLX has a Quick ratio of 0.97. This is comparable to the rest of the industry: RBLX outperforms 48.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 18.60% over the past year.
RBLX shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.39%.
RBLX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 47.93% yearly.
EPS 1Y (TTM)18.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.12%
Revenue 1Y (TTM)27.39%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%50.51%

3.2 Future

Based on estimates for the next years, RBLX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.51% on average per year.
Based on estimates for the next years, RBLX will show a very strong growth in Revenue. The Revenue will grow by 22.22% on average per year.
EPS Next Y-17.09%
EPS Next 2Y2.95%
EPS Next 3Y8.36%
EPS Next 5Y25.51%
Revenue Next Year35.1%
Revenue Next 2Y29.37%
Revenue Next 3Y26.76%
Revenue Next 5Y22.22%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

RBLX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 99.41
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.95%
EPS Next 3Y8.36%

More info and screens

0

5. Dividend

5.1 Amount

RBLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROBLOX CORP -CLASS A

NYSE:RBLX (9/26/2025, 8:26:18 PM)

After market: 135.08 +0.02 (+0.01%)

135.06

+3.02 (+2.29%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners81.2%
Inst Owner Change5.25%
Ins Owners4.41%
Ins Owner Change-0.25%
Market Cap93.63B
Analysts77.5
Price Target143.41 (6.18%)
Short Float %2.9%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.17%
Min EPS beat(2)-9.21%
Max EPS beat(2)21.55%
EPS beat(4)3
Avg EPS beat(4)13.56%
Min EPS beat(4)-9.21%
Max EPS beat(4)28.29%
EPS beat(8)7
Avg EPS beat(8)14.35%
EPS beat(12)8
Avg EPS beat(12)6.28%
EPS beat(16)9
Avg EPS beat(16)-3.9%
Revenue beat(2)2
Avg Revenue beat(2)8.35%
Min Revenue beat(2)3.4%
Max Revenue beat(2)13.29%
Revenue beat(4)3
Avg Revenue beat(4)5.57%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)13.29%
Revenue beat(8)5
Avg Revenue beat(8)3.32%
Revenue beat(12)5
Avg Revenue beat(12)-3.21%
Revenue beat(16)5
Avg Revenue beat(16)-7.27%
PT rev (1m)6.69%
PT rev (3m)81.23%
EPS NQ rev (1m)-32.9%
EPS NQ rev (3m)-53.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-15.08%
Revenue NQ rev (1m)6.93%
Revenue NQ rev (3m)23.47%
Revenue NY rev (1m)-1.47%
Revenue NY rev (3m)9.24%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.27
P/FCF 99.41
P/OCF 87.09
P/B 265.08
P/tB 506.7
EV/EBITDA N/A
EPS(TTM)-1.4
EYN/A
EPS(NY)-1.33
Fwd EYN/A
FCF(TTM)1.36
FCFY1.01%
OCF(TTM)1.55
OCFY1.15%
SpS5.8
BVpS0.51
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.14%
ROE -269.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.01%
FCFM 23.41%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 2.85
Debt/FCF 1.07
Debt/EBITDA N/A
Cap/Depr 58.58%
Cap/Sales 3.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 6.56
F-Score6
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.12%
EPS Next Y-17.09%
EPS Next 2Y2.95%
EPS Next 3Y8.36%
EPS Next 5Y25.51%
Revenue 1Y (TTM)27.39%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%50.51%
Revenue Next Year35.1%
Revenue Next 2Y29.37%
Revenue Next 3Y26.76%
Revenue Next 5Y22.22%
EBIT growth 1Y7.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.58%
EBIT Next 3Y60.52%
EBIT Next 5Y42.84%
FCF growth 1Y889.49%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y176.66%
OCF growth 3Y7.65%
OCF growth 5Y52.65%